John Prendergast
Founder at PALATIN TECHNOLOGIES, INC.
Net worth: 190 835 $ as of 2024-03-30
Profile
John K.
A.
Prendergast was the founder of Avigen, Inc. (founded in 1992) where he served as the Lead Director from 1992 to 2009.
He is also the founder of Palatin Technologies, Inc. (founded in 1986) where he currently holds the position of Non-Executive Chairman.
Dr. Prendergast is also the founder of Antyra, Inc., Nejo, Inc...His current job(s) include being the Executive Chairman at Recce Pharmaceuticals Ltd.
since 2018, a Director at Ingenex, Inc., the Lead Independent Director at Elusys Therapeutics, Inc., the Lead Independent Director at Scorpius Holdings, Inc. since 2016, and the President of SummerCloud Bay, Inc. since 1993.
His former job(s) include being the Chairman & Chief Executive Officer of AVAX Technologies, Inc. from 1996 to 2013, the Lead Director of MediciNova, Inc. from 2004 to 2011, and the Managing Director of Castle Group Ltd.
from 1991 to 1997.
He also held positions as a Managing Director at Paramount Capital Investments LLC and as a Director at Osaka Exchange, Inc. In terms of education, Dr. Prendergast holds an MBA from Harvard University and has graduate and doctorate degrees from The University of New South Wales.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-12-06 | 306,819 ( 0.15% ) | 88 075 $ | 2024-03-30 | |
| 2023-09-26 | 34,310 ( 0.21% ) | 64 160 $ | 2024-03-30 | |
SCORPIUS HOLDINGS, INC.
0.66% | 2023-08-17 | 238,272 ( 0.66% ) | 38 600 $ | 2024-03-30 |
John Prendergast active positions
| Companies | Position | Start |
|---|---|---|
| PALATIN TECHNOLOGIES, INC. | Founder | 1986-11-20 |
| SCORPIUS HOLDINGS, INC. | Director/Board Member | 2016-04-25 |
| RECCE PHARMACEUTICALS LTD | Chairman | 2019-07-08 |
| SummerCloud Bay, Inc. | President | 1992-12-31 |
Ingenex, Inc.
 Ingenex, Inc. BiotechnologyHealth Technology Part of Titan Pharmaceuticals, Inc., Ingenex, Inc. is a private company based in San Francisco, CA. | Director/Board Member | - |
| Nejo, Inc. | Founder | - |
Elusys Therapeutics, Inc.
 Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | Director/Board Member | - |
Former positions of John Prendergast
| Companies | Position | End |
|---|---|---|
| AVAX TECHNOLOGIES, INC. | Chief Executive Officer | 2012-12-31 |
| MEDICINOVA, INC. | Director/Board Member | 2011-09-24 |
| ░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
Training of John Prendergast
| Harvard University | Masters Business Admin |
| The University of New South Wales | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| AVAX TECHNOLOGIES, INC. | Health Technology |
| PALATIN TECHNOLOGIES, INC. | Health Technology |
| MEDICINOVA, INC. | Health Technology |
| SCORPIUS HOLDINGS, INC. | Health Technology |
| Private companies | 10 |
|---|---|
Avigen, Inc.
 Avigen, Inc. Medical SpecialtiesHealth Technology Avigen, Inc. produces and sells drugs, animal health products, and chemicals. The firm also develops and commercializes small molecules of therapeutics and biologics for use in the treatment of serious neurological and neuromuscular disorders. The company was founded in 1992 and is headquartered in La Jolla, CA. | Health Technology |
Ingenex, Inc.
Ingenex, Inc. BiotechnologyHealth Technology Part of Titan Pharmaceuticals, Inc., Ingenex, Inc. is a private company based in San Francisco, CA. | Health Technology |
Elusys Therapeutics, Inc.
Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | Health Technology |
Castle Group Ltd.
 Castle Group Ltd. Real Estate DevelopmentFinance Part of Places for People Group Ltd., Castle Group Ltd. is a holding British company with interests in residential property management and portable appliance testing. The private company is based in Scarborough, UK. Castle Group was acquired by Paladin Group Ltd. on July 14, 2006 for $14.74 million. | Finance |
| SummerCloud Bay, Inc. | |
Antyra, Inc.
 Antyra, Inc. Pharmaceuticals: MajorHealth Technology Antyra, Inc. develops cancer therapeutics. Its products include lead programs, a program to generate and develop disease-specific therapeutics; oncology leads, such as IGF-1R Antagonist, which represent a clinical strategy for the treatment of pancreatic and other cancers; and ANT-G12, a technology that isolates cytotoxic peptimetics that bind to cell surface targets expressed in a disease-specific context. The company was founded by by John K. A. Prendergast and Arthur J. Blume in 1996 and is headquartered in Edison, NJ. | Health Technology |
| Paramount Capital Investments LLC | |
| Recce Pharmaceuticals Ltd. | |
| Nejo, Inc. | |
Osaka Exchange, Inc.
 Osaka Exchange, Inc. Investment Banks/BrokersFinance Osaka Exchange, Inc. provides markets for index futures, index options, and security options. It also conducts the administration of trading, the administration of transaction participants, and the development and investigative research for new products and trading frameworks. The company was founded on April 1, 1949 and is headquartered in Osaka, Japan. | Finance |
- Stock Market
- Insiders
- John Prendergast
